Global Sexual Dysfunction Drugs Market 2018: By Types, Size, Key Developers, Demand, Revenue, Opportunities, Growth Factors, Trend & forecast 2025

Description:

This report focuses on the global Sexual Dysfunction Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Sexual Dysfunction Drugs development in United States, Europe and China.

Sexual dysfunctions include sexual disorders of men and women that can interfere with their sexual performance, leading to unsatisfied sexual intercourse. The major drugs used in this market are PDE5 inhibitors, whereas other drugs such as hormone-related and transurethral also have a presence in the market.

The sexual dysfunction oral drugs segment accounted for the majority market share during 2017 and will continue to grow during the forecast period. The increasing cases of sexual dysfunctions are driving the need for oral therapies such as 5HT1A receptor agonist. The demand for sexual dysfunction oral drugs such as ED drugs will further increase due to the rising awareness among healthcare professionals.

The demand for sexual dysfunction drugs is increasing due to the rising prevalence of chronic diseases such as prostate cancer, diabetes mellitus, and CVD. The market will continue to grow in the region in the forthcoming years due to the rise in unhealthy lifestyle habits and the increased risk of developing sexual dysfunctions among the population.

In 2017, the global Sexual Dysfunction Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/2287542

The key players covered in this study

Pfizer

GlaxoSmithKline

Merck

Eli Lilly

AbbVie

Bayer

Teva Pharmaceutical Industries

Takeda

Apricus Biosciences

Emotional Brain

Ivix LLX

Leadiant Biosciences

NexMed

S1 Biopharma

Vietstar Biomedical Research

Market segment by Type, the product can be split into

Oral Therapy

Intracavernosal Therapy

Hormonal Therapy

Transurethral Therapy

Market segment by Application, split into

Male

Female

Market segment by Regions/Countries, this report covers

United States

Europe

China

Japan

Southeast Asia

India

Central & South America

The study objectives of this report are:

To analyze global Sexual Dysfunction Drugs status, future forecast, growth opportunity, key market and key players.

To present the Sexual Dysfunction Drugs development in United States, Europe and China.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Sexual Dysfunction Drugs are as follows:

History Year: 2013-2017

Base Year: 2017

Estimated Year: 2018

Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Browse the complete report @ http://www.orbisresearch.com/reports/index/global-sexual-dysfunction-drugs-market-size-status-and-forecast-2018-2025

Some Points from TOC:

Chapter One: Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered

1.4 Market Analysis by Type

1.4.1 Global Sexual Dysfunction Drugs Market Size Growth Rate by Type (2013-2025)

1.4.2 Oral Therapy

1.4.3 Intracavernosal Therapy

1.4.4 Hormonal Therapy

1.4.5 Transurethral Therapy

1.5 Market by Application

1.5.1 Global Sexual Dysfunction Drugs Market Share by Application (2013-2025)

1.5.2 Male

1.5.3 Female

1.6 Study Objectives

1.7 Years Considered

Chapter Two: Global Growth Trends

2.1 Sexual Dysfunction Drugs Market Size

2.2 Sexual Dysfunction Drugs Growth Trends by Regions

2.2.1 Sexual Dysfunction Drugs Market Size by Regions (2013-2025)

2.2.2 Sexual Dysfunction Drugs Market Share by Regions (2013-2018)

2.3 Industry Trends

2.3.1 Market Top Trends

2.3.2 Market Drivers

2.3.3 Market Opportunities

Chapter Three: Market Share by Key Players

3.1 Sexual Dysfunction Drugs Market Size by Manufacturers

3.1.1 Global Sexual Dysfunction Drugs Revenue by Manufacturers (2013-2018)

3.1.2 Global Sexual Dysfunction Drugs Revenue Market Share by Manufacturers (2013-2018)

3.1.3 Global Sexual Dysfunction Drugs Market Concentration Ratio (CRChapter Five: and HHI)

3.2 Sexual Dysfunction Drugs Key Players Head office and Area Served

3.3 Key Players Sexual Dysfunction Drugs Product/Solution/Service

3.4 Date of Enter into Sexual Dysfunction Drugs Market

3.5 Mergers & Acquisitions, Expansion Plans

If you have any enquiry before buying a copy of this report@ http://www.orbisresearch.com/contacts/enquiry-before-buying/2287542

….Continued

About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Us:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas - 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019
Email ID: sales@orbisresearch.com

This release was published on openPR.